Intravenous treprostinil via an implantable pump in pediatric pulmonary arterial hypertension

by Susanna Desole, Manuel Jonas Richter, Alexander Heine, Ralf Ewert
Published 2018-12-01

Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension.

by Manuel Jonas Richter, Svenja Lena Tiede, Natascha Sommer, Thomas Schmidt, Werner Seeger, Hossein Ardeschir Ghofrani, Ralph Schermuly, Henning Gall
Published 2016-01-01

Physical Activity and Mental Health of Patients with Pulmonary Hypertension during the COVID-19 Pandemic

by Carolin Leoni Dobler, Britta Krüger, Jana Strahler, Christopher Weyh, Kristina Gebhardt, Khodr Tello, Hossein Ardeschir Ghofrani, Natascha Sommer, Henning Gall, Manuel Jonas Richter, Karsten Krüger
Published 2020-12-01

The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension.

by Manuel Jonas Richter, Katrin Milger, Sarah Haase, Natascha Sommer, Khodr Tello, Werner Seeger, Eckhard Mayer, Christoph Benjamin Wiedenroth, Friedrich Grimminger, Wolfgang George, Hossein Ardeschir Ghofrani, Stefan Guth, Henning Gall
Published 2016-01-01

Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion

by Khodr Tello, Andreas Hoffmann, Björn Beutel, Timm Greulich, Claus Franz Vogelmeier, Manuel Jonas Richter, Stefan Kuhnert, Tobias Böselt, Peter Alter, Angelique Holland, Marco Idzko, Roland Buhl, Andreas Rembert Koczulla
Published 2019-01-01